Muthusamy Shanmugam, HEAD OF R&D, COO-NOVITIUM Operations at ANI PHARMACEUTICALS INC (ANIP), sold 50,000 shares at $63.06 ($3.2M) on 2023-08-28, disclosed to the SEC on 2023-08-30.
Open-market sale of $3.2M ANIP by HEAD OF R&D, COO-NOVITIUM Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.06 | 25,000 | $1.6M | 49.9% |
| 2 | $63.37 | 25,000 | $1.6M | 50.1% |
| Total | $63.22 avg | 50,000 | $3.2M | 100% |
| Filing → |
| ANIP | SELL | 2025-05-13 | $54K | — | Filing → |
| ANIP | SELL | 2024-07-19 | $170K | — | Filing → |
| ANIP | SELL | 2024-07-17 | $3.9M | — | Filing → |